Haatch

How does our relationship with the British Business Bank work? Your question is answered! #BBB #coinvestment #SEIS #EIS

🎙️ Less than 1 week to go until we kick off Becoming an Angel Investor - Part of the Regional Embracing Diversity Roadshow! UKBAA and the British Business Bank are launching a nationwide series of regional events to expand access to angel investing and empower investors to build more diverse, high-performing portfolios. 🚅 The first stop? Edinburgh on Tuesday 18th March! In partnership with leading angel groups and syndicates, this series will offer expert insights and practical guidance to: 🔹 Support and welcome investors from diverse backgrounds, making angel investing more inclusive and accessible 🔹 Demystify angel investing for those new to the space, covering key opportunities and challenges, plus how to get started 🔹 Equip existing investors with strategies to back diverse founders and unlock stronger portfolio performance Hosted by Apollo Informal Investments, this is a must-attend event for investors, angel groups and industry leaders looking to unlock new opportunities, drive innovation, and foster more inclusive growth. 🔗 More dates to be announced - sign up to get involved! https://lnkd.in/e4mdN44K Anglia Capital Group - Hannah Brynn | Apollo Informal Investments - Michiel Smith | angelgroups - Martin Avison | Gateway Angels - Katie Nicholson | Minerva Business Angels - Mark Tock | Angel Investors Bristol - Ben Cooper | Oxford Innovation - Richard Cooper

How far we’ve come. At Haatch, we’re building something special. Our portfolio is still young. 90% of our investments are under four years old, but we’re already seeing incredible momentum. Through it all, we’ve remained obsessed with one thing: investor experience. We believe backing high-growth startups should be as seamless, transparent, and rewarding as possible. That’s why we put so much effort into clear communication, easy-to-use platforms, and making sure our investors feel part of the journey. #VentureCapital #Startups #Investing #Haatch #SEIS #EIS

🐣 Major Milestone: Haatch delivers up to 6.55x returns to investors in just 4 years! 🚀 Please note: that these returns include our upfront initial fee but are gross of our performance fee and any tax reliefs claimed by investors. This exit is not only a fantastic outcome for investors but also a testament to the power of the Enterprise Investment Scheme (EIS) in supporting high-growth UK businesses. Investing through EIS enables the scaling of B2B software companies, like Re-flow Field Management, who are driving efficiency in construction, highways, and engineering. ⚡  Why Does This Matter for Financial Advisors? ✅  Tax-efficient planning – EIS offers up to 30% income tax relief, CGT deferral, up to 100% IHT relief and loss relief to offset company losses/ failures. ✅  Proven investment potential – Strong exits, like Re-Flow, showcase the potential for significant returns. Watch this space for more exit announcements soon 👀 ✅  Supporting UK innovation – Backing disruptive, high-growth companies that are solving real inefficiencies. ⚡ Why Is This Exit Important for Haatch? ✅  Another example of Haatch’s ability to identify, scale, and exit high-potential companies. ✅ A proven track record of delivering strong investor outcomes through EIS. ✅  Reinforces Haatch’s position as a leading early-stage investor in B2B SaaS businesses. ‼️ Our EIS is actively deploying this tax year, and it’s not too late to recommend us. If you’re a financial adviser looking to help clients with EIS tax planning, let’s chat about how we can work together. A huge thank you to Haatch's A team for their ongoing commitment to supporting EIS-backed businesses - this is why EIS remains such a powerful tool for both investors and the UK economy! Don't invest unless you are prepared to lose all of your money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more: https://lnkd.in/g6ntu7Q2 #EIS #Investment #TaxPlanning #FinancialAdvisors #WealthManagement #B2BSaaS #Innovation #Haatch #Exit

🚀 Why We Invested in Re-flow Field Management At Haatch, we back businesses, solving deep pain points that create massive impact for organisations. Those that become indispensable to their customers and highly attractive to acquirers. That’s exactly what we saw in Re-Flow. 📍 The Problem: Construction, highways, and civil engineering firms were drowning in paperwork, struggling with miscommunication, and navigating complex compliance challenges. 💡 The Solution: Re-Flow’s software transformed field management, enabling real-time communication, automated workflows, and seamless compliance tracking. The results? Faster decisions, fewer errors, and a massive boost in efficiency. 📈 The Growth Story: When we invested in 2020, Re-Flow had 1,500 users and £350k ARR. By 2024, they scaled to over 30,000 users. ✅ The Outcome: Last week, Re-Flow became our latest exit—delivering up to 6.5x returns for our investors. It’s a textbook example of why we invest in B2B SaaS: strong retention, scalability, and clear pathways to exit. With 80% of our portfolio still under four years old, we’re just getting started. Onward! 🔥 #VentureCapital #SaaS #Startups #EIS #Investment #Growth

This International Women’s Day, we’re spotlighting just a few of the incredible female founder led companies in our portfolio. Read more here about them here: https://lnkd.in/eS5tASZZ Bridget Johns-Pavlopoulos / Tash Grossman / Holly Holland (Financielle) & Laura Pomfret (Financielle) 💸 / Shana Chu / Yasmin Greenaway FRSA / Mary Lin / Rebecca Griffiths / Amanda Sparkes / Nuria M. / Molly Johnson-Jones / Lucy Adams / Myra Khanna & Caitlin Foley / Nicola V.

It's International Women’s Day tomorrow, and we’re celebrating some of the trailblazing women leading companies across our portfolio. We’re proud to back visionary female founders driving innovation, including Tash Grossman, founder & CEO of Slip, who has recently been named one of TechRound’s Top 50 Women in Tech! 👏 A huge congratulations to Tash and all the other inspiring women on the list—your impact is transforming industries and redefining the future. 🎉 🔗 TechRound’s Top 50 Women in Tech: https://lnkd.in/eyu_6q7c #IWD #top50 #fintech

Bourn is a fintech pioneer tackling one of UK SMEs' biggest challenges: cash flow. We are thrilled to lead a £1.5 million seed investment into Bourn, alongside our friends at Love Ventures and Portfolio Ventures Read more here: https://lnkd.in/dFdSHvXP #fintech #vc #investment

🚀 EXIT ANNOUNCEMENT: RE-FLOW 🚀 We’re thrilled to share Re-flow Field Management's successful all-cash exit, which has delivered up to 6.55x returns for Haatch EIS investors. When we first backed Re-flow in 2020, they had 1,500 users and £27K MRR. Fast—forward to today, and they’ve scaled to 30,000+ users. Their field management SaaS platform has transformed how infrastructure and construction teams operate, attracting major clients like AA, Tarmac, and WJ Group. 📈 EIS Fund 4 (2020 investment): 6.55x return 📈 EIS Fund 8 (2022 investment): 4.10x return With 90% of our portfolio still under four years old, we’re entering an exciting phase where more businesses will begin to reach maturity and prepare for exit. Congratulations to the Re-flow team and our Haatch investors on this fantastic milestone! Past performance is not a reliable indicator of future returns. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more. https://lnkd.in/dNJiNB6U. #VC #SaaS #EIS #Investing #Exits #Haatch

The brutal truth about drug development? Clinical trial failures crush innovation, burn billions, and stall crucial treatments. For smaller biotechs, one stumble can be fatal. That's why we invested in Turing Biosystems. Turing isn't just another AI company. It's revolutionising drug development with an AI platform that uses real-world patient data to drastically de-risk clinical trials. Think smarter, data-driven decisions BEFORE you commit millions. Their auditable, interpretable AI gives biotech and pharma companies the edge they desperately need. Thrilled to be partnering with the Turing team. Watch this space. Read more about why we believe Turing is a game-changer: #AI #DrugDevelopment #Biotech #Pharma #ClinicalTrials